IMJUDO conc perf 25 mg/1.25ml vial 1.25 ml
7680687060011
CH-68706
L01FX20
07.16.1.
Reimbursement limitations:
IMJUDO_HCC
HCC
IMJUDO en association avec IMFINZI est remboursé pour le traitement des patients atteints de …
1 / 3
google
Details
- Product number
- 6870601
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- tremelimumabum 25 mg, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, dinatrii edetas corresp. natrium 0.012 mg, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1.25 ml.
Articles (1)
Imjudo 25 mg/1,25 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.012 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1570.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2025
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68706
- Drug name
- Imjudo, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FX20
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/09/2023
- Authorization expiration date
- 12/09/2028
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IMJUDO conc perf 25 mg/1.25ml vial 1.25 ml
- Description (DE)
- IMJUDO Inf Konz 25 mg/1.25ml Vial 1.25 ml
- Market launch
- 13/09/2023
- Narcotic (BTM)
- No